In 164 eyes measuring 26.04–29.72 mm, Holladay 1 NLR and SRK/T WK2 achieved an RMSAE of 0.393 D; some adjusted older formulas underperformed newer methods.
In 255 long eyes, Hoffer QST had the lowest absolute error at 0.33 D, yet only about 70% of results from it and the strongest alternatives fell within ±0.50 D.
In a randomized study of 140 patients, both OVDs produced comparable IOP, endothelial and visual outcomes through 90 days; no IOP spike of at least 30 mmHg occurred.
In a retrospective sequential cohort, the newer Liberty 677CMY improved several intermediate measures, but the primary binocular endpoint did not reach P<.05.
In a prospective series of 30 patients, bilateral SwissPhob implantation produced approximately 20/25 binocular vision at 66 cm and favorable objective optics, but there was no control group.
In an uncontrolled prospective series of 49 patients, the Galaxy IOL provided a functional defocus range to −2.50 D, but it was not compared with another presbyopia-correcting lens.
In a prospective cohort of 122 eyes, vision and satisfaction after PanOptix were similar across the 0.3-mm chord-μ threshold, but only 50 patients completed questionnaires.
In a masked randomized trial, both strategies produced good distance and intermediate vision, but mini-monovision reduced low-contrast acuity and slightly increased glare.
In 70 patients, aligning a Tecnis Toric IOL to the steep meridian with calculated SIA=0 reduced vector error, while the residual-cylinder difference did not reach significance.
In 100 short eyes, LenSx and Catalys produced similar ultrasound use and endothelial change while differing in laser time and capsulotomy-edge morphology.